Ogeston-H2 Injection
Marketer
Orange Biotech Pvt Ltd
Salt Composition
Hydroxyprogesterone (500mg)
Overview Ogeston-H2 Injection
Hydroxyprogesterone caproate injection is employed to inhibit preterm labor in expectant mothers, thereby mitigating the likelihood of premature delivery. This medication helps prevent miscarriage and reduces the recurrence of premature birth in women with a prior history of preterm delivery. Administration of hydroxyprogesterone caproate injection is exclusively conducted by, or under the direct oversight of, a physician. Dosage and duration are determined and prescribed solely by your doctor. Adhere strictly to the prescribed treatment regimen. Frequently reported adverse effects include localized injection site reactions, nausea, pruritus, diarrhea, and skin rashes. Report any bothersome side effects to your physician; management strategies may be available. This medication can influence blood glucose levels; therefore, regular blood sugar monitoring is crucial. Immediately notify your doctor if you observe jaundice, dark urine, or abdominal discomfort during treatment. Prior to commencing treatment, disclose any pre-existing circulatory problems, diabetes, hepatic disorders, or concurrent medications to your physician. Such conditions may compromise the efficacy or alter the pharmacokinetic profile of this medication.
Uses of Ogeston-H2 Injection
Avoiding Early Delivery
Major Benefits of Ogeston-H2 Injection:
Administering this medication will be done by your healthcare provider. Self-medication is not permitted.
Common Side effects of Ogeston-H2 Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Ogeston-H2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ogeston-H2 Injection works:
Ogeston-H2 Injection contains a progestin, a type of female hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ogeston-H2 Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Ogeston-H2 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have indicated minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Ogeston-H2 poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to infants.
DrivingSAFE
Driving ability is typically unaffected by Ogeston-H2 Injection.
KidneyCONSULT YOUR DOCTOR
Data on Ogeston-H2 Injection's use in individuals with renal impairment is scarce. Physician consultation is advised. The drug's progesterone component may induce fluid retention in patients with pre-existing kidney conditions.
LiverUNSAFE
The use of Ogeston-H2 Injection is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical advice.
What if you forget to take Ogeston-H2 Injection :
Omit a dose of Ogeston-H2 Injection? Seek your physician's advice.
Facts to Know About Ogeston-H2 Injection
| Label | Value |
|---|---|
| Chemical Category | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Actions | First-generation progestins |
3,018 People bought this recently